Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BRØDLØS APOTEK AS
AS
Active
Org 926355163
Retail sale of pharmaceutical products · NACE 4773
Est. 2021
12 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
NOK 2,4M
-92% vs 2022
EBITDA margin
4.8%
-94% vs 2022
Equity ratio
10.0%
Financial strength
Net profit 2023
NOK 150K
-88% vs 2022
EBITDA — year on year
NOK millions
3M
2M
1M
1M
0M
1M
2021
2M
+100%
2022
0M
-100%
2023
Key figures
Annual report 2023
Revenue
NOK 2,4M
-92%
EBITDA
NOK 118K
-94%
Net profit
NOK 150K
-88%
Total assets
NOK 4,6M
-8%
Equity
NOK 461K
+48%
Employees
12
—
Company information
Legal name
BRØDLØS APOTEK AS
Org number
926355163
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
8. januar 2021
Share capital
NOK 3 000 000
Employees
12 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-01-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Eierskap og drift av apotek, handel med apotekvarer og relaterte produkter, aktuelle konsulent og rådgivningstjenester.
Contact
Address
Phone
+4769172000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in
All Norway companies
Revenue
NOK millions
0M
9M
17M
26M
35M
13M
2021
30M
2022
2M
2023
EBITDA
NOK millions
0M
1M
1M
2M
2M
1M
2021
2M
2022
0M
2023
Income statement
NOK thousands
Item
2021
2022
2023
Revenue
13 306
30 275
2 436
Staff expenses
−2 022
−4 798
−412
EBITDA
1 200
1 811
118
Depreciation & amort.
−86
−150
57
EBIT
1 114
1 661
174
Net financials
−38
−37
0
Profit before tax
1 076
1 624
174
Tax
239
374
25
Net profit
836
1 250
150
Balance sheet
NOK thousands
Item
2021
2022
2023
Total assets
5 570
5 020
4 622
Equity
61
311
461
Long-term debt
1 018
0
0
Short-term debt
4 492
4 709
4 161
Total debt
5 510
4 709
4 161
Financial ratios
5-year trend
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
2021
2023
Equity ratio
10.0%
This company
38.2%
Market median
-74% vs market
2021
2023
Return on equity
32.5%
This company
18.4%
Market median
+77% vs market
2021
2023
Net profit margin
6.1%
This company
8.1%
Market median
-25% vs market
2021
2023
Asset turnover
0.53×
This company
1.12×
Market median
-53% vs market
2021
2023
Debt / equity
9.03×
This company
0.62×
Market median
-1356% vs market
2021
2023
Annual reports & filings
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
JD
Jasmin Dinarevic
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
BM
Børge Moholt
Chairman
2023
ØA
Øystein Askim
Board of Directors
2023
Former (1)
VK
Vedad Kulic
Deputy Chairman
2021 – 2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
50%
50%
2022
Unknown
Individual
50%
50%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of BRØDLØS APOTEK AS also hold positions in
0
other companies.
Person
Role here
Other companies
Jasmin Dinarevic
Chief Executive Officer
0 companies
Vedad Kulic
Deputy Chairman
0 companies
Børge Moholt
Chairman
0 companies
Øystein Askim
Board of Directors
0 companies